Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shannon N. Westin
Observed names:
S Westin,
S. N. Westin,
S. Westin,
S.N. Westin
Institution:
The University of Texas MD Anderson Cancer Center
Observed institution:
The University of Texas MD Anderson Cancer Center
OpenAlex ID:
A5109547578
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
2014
·
I Brana
, R Berger
, et al.
·
British Journal of Cancer
·
89
PDF
Phase I expansion of olaparib (PARP inhibitor) and AZD5363 (AKT inhibitor) in recurrent ovarian, endometrial and triple negative breast cancer
2017
·
S. Westin
, J. Litton
, et al.
·
Annals of Oncology
·
16
PDF
IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203
2019
·
A.R. Yeung
, S. Pugh
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
15
NCI10329: Phase Ib Sequential Trial of Agents against DNA Repair (STAR) Study to investigate the sequential combination of the Poly (ADP-Ribose) Polymerase inhibitor (PARPi) olaparib (ola) and WEE1 inhibitor (WEE1i) adavosertib (ada) in patients (pts) with DNA Damage Response (DDR)-aberrant advanced tumors, enriched for BRCA1/2 mutated and CCNE1 amplified cancers
2022
·
T.A. Yap
, N. Ngoi
, et al.
·
European Journal of Cancer
·
14
A phase I trial of mesenchymal stem cells transfected with a plasmid secreting interferon beta in advanced ovarian cancer
2018
·
A. Olson
, F. Marini
, et al.
·
Cytotherapy
·
2
Sleep disturbances: A critical issue among gynecologic cancer survivors
2013
·
C. Tung
, S. Westin
, et al.
·
Gynecologic Oncology
·
2
DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations
2022
·
N. Ngoi
, P.G. Pilie
, et al.
·
European Journal of Cancer
·
1
PDF
Patient preferences for maintenance therapy versus routine surveillance: Gain in progression-free survival and risks of adverse effects
2020
·
C.C. Sun
, E. Molina
, et al.
·
Gynecologic Oncology
·
1
Is an endometrial cancer diagnosis a 'teachable moment' leading to weight loss among obese women? A case-control study
2020
·
R.F. Harrison
, H. Zhao
, et al.
·
Gynecologic Oncology
·
1
Homologous recombination deficiency score testing in endometrial cancer
2020
·
J.M. Hansen
, K. Ring
, et al.
·
Gynecologic Oncology
·
1
The utility of preoperative PET/CT in the detection of extrauterine disease in high-risk endometrial cancer: A prospective study
2018
·
K.I. Stewart
, B. Chasen
, et al.
·
Gynecologic Oncology
·
1
Challenging the paradigm of progesterone-only therapy for early endometrial cancer: Results of a prospective trial of the levonorgestrel intrauterine system
2016
·
S.N. Westin
, C.C.L. Sun
, et al.
·
Gynecologic Oncology
·
1
PDF
Abstract 1041: Extracellular vesicle-associated noncanonical ORFs as biomarkers of surgical outcome and chemoresistance in ovarian cancer
2026
·
Tatiana V. Karpinets
, Xiaogang Wu
, et al.
·
Cancer Research
Abstract 3907: Molecular determinants of response in laparoscopically triaged advanced ovarian cancer.
2026
·
Sara Corvigno
, Nicholas W. Bateman
, et al.
·
Cancer Research
Abstract 1799: Ferroportin mediates bevacizumab resistance and ferroptosis evasion in ovarian cancer
2026
·
Zonghao Tang
, Amir A. Jazaeri
, et al.
·
Cancer Research
Socioeconomic barriers to care in advanced ovarian cancer: Does a 'one size fits all' model exist when treated at a NCI-designated tertiary cancer center?
2020
·
S.M. Moufarrij
, A.K. Sood
, et al.
·
Gynecologic Oncology
Is platinum-free interval relevant in recurrent uterine serous carcinoma?
2020
·
R.N. Beavers
, B. Fellman
, et al.
·
Gynecologic Oncology
Dasatinib, paclitaxel and carboplatin in women with advanced-stage and recurrent endometrial cancer: A pilot clinical and translational study
2019
·
R.L. Coleman
, W. Hu
, et al.
·
Gynecologic Oncology
Survival Outcomes of Stage IIIC Endometrioid and Non-Endometrioid Endometrial Cancer Treated with Combined Modality Adjuvant Therapy
2018
·
B.V. Chapman
, C.W. Swanick
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Quality-Adjusted Survival in Women with Gynecologic Malignancies Receiving IMRT after Surgery: A Patient Reported Outcome Study of RTOG 1203
2018
·
A.A. Konski
, S. Deshmukh
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
From unresectable to cancer-free at interval surgery: An evaluation of complete pathologic responders
2018
·
C.J. LaFargue
, N.D. Fleming
, et al.
·
Gynecologic Oncology
Concordance of laparoscopy in predicting intraperitoneal spread and residual disease at tumor reductive surgery in advanced ovarian cancer
2018
·
J.M. Hansen
, A.K. Sood
, et al.
·
Gynecologic Oncology
Prospective evaluation of quality of life and sexual functioning after radical trachelectomy for early-stage cervical cancer
2016
·
N.D. Fleming
, P.T. Ramirez
, et al.
·
Gynecologic Oncology
A phase II study of multimodal optical imaging to evaluate tumor margins for potential use in conservative, uterine-sparing surgery for women with endometrial cancer
2013
·
P. Ramirez
, R. Broaddus
, et al.
·
Gynecologic Oncology
Improvement in quality of life after robotic surgery results in patient satisfaction
2013
·
P. Soliman
, C. Sun
, et al.
·
Gynecologic Oncology
Show more works
View as search
Works count:
27
Citation count:
144
H-index:
4
I10-index:
4
Year
Topic
Type
